1-5 of 5
Hailing Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, Lingegowda S. Mangala, Geoffrey Bartholomeusz, Lakesla R. Iles, Nicholas B. Jennings, Ahmed Ashour Ahmed, Anil K. Sood, Gabriel Lopez-Berestein, Zhen Lu, Robert C. Bast, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 5050.
https://doi.org/10.1158/1078-0432.CCR-20-3198
Published: 15 September 2020
View article titled, Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability
Open the PDF for Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability in another window
Journal Articles

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

Hailing Yang, Zhang Shu, Yongying Jiang, Weiqun Mao, Lan Pang, Abena Redwood, Sabrina L. Jeter-Jones, Nicholas B. Jennings, Argentina Ornelas, Jinhua Zhou, Cristian Rodriguez-Aguayo, Geoffrey Bartholomeusz, LaKesla R. Iles, Niki M. Zacharias, Steven W. Millward, Gabriel Lopez-Berestein, Xiao-Feng Le, Ahmed A. Ahmed, Helen Piwnica-Worms, Anil K. Sood, Robert C. Bast, Zhen Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5702–5716.
https://doi.org/10.1158/1078-0432.CCR-18-3448
Published: 13 September 2019
View article titled, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers
Open the PDF for 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, Lingegowda S. Mangala, Geoffrey Bartholomeusz, Lakesla R. Iles, Nicholas B. Jennings, Ahmed Ashour Ahmed, Anil K. Sood, Gabriel Lopez-Berestein, Zhen Lu, Robert C. Bast, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (20): 5072–5084.
https://doi.org/10.1158/1078-0432.CCR-18-0504
Published: 15 October 2018
View article titled, Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability
Open the PDF for Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability in another window
Includes: Supplementary data
Journal Articles

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel

Jinhua Zhou, Albandri Alfraidi, Shu Zhang, Janice M. Santiago-O'Farrill, Venkata Krishna Yerramreddy Reddy, Abdulkhaliq Alsaadi, Ahmed A. Ahmed, Hailing Yang, Jinsong Liu, Weiqun Mao, Yan Wang, Hiroshi Takemori, Hariprasad Vankayalapati, Zhen Lu, Robert C. Bast, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 1945–1954.
https://doi.org/10.1158/1078-0432.CCR-16-1562
Published: 13 April 2017
View article titled, A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel
Open the PDF for A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel in another window
Includes: Supplementary data
Journal Articles

Abstract PR18: Survival of ARHI-induced dormant autophagic cell death in vivo requires permissive levels of VEGF, IL-8, and IGF-1 in the tumor microenvironment.

Zhen Lu, Aaron F. Orozco, Hailing Yang, Margie N. Sutton, Yan Wang, Weiqun Mao, Douglas A. Levine, Robert C. Bast, Jr, Robert C. Bast, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): PR18.
https://doi.org/10.1158/1557-3265.OVCA15-PR18
Published: 15 January 2016
View article titled, Abstract PR18: Survival of ARHI-induced dormant autophagic cell death in vivo requires permissive levels of VEGF, IL-8, and IGF-1 in the tumor microenvironment.